Greenland Mines Sets Q4 Biotech Spin-Off as It Sharpens Critical Minerals Focus

Greenland Mines Ltd (NASDAQ: GRML) has announced a series of corporate milestones as it sharpens its focus on critical minerals, including the planned spin-off of its biotechnology division in the fourth quarter of 2026. The move comes as the company transitions into a dedicated rare earths and critical minerals enterprise, with Nasdaq formally approving its application related to a March 2026 transaction, bringing the company into full compliance with listing requirements.

The company has also completed its acquisition of the Sarfartoq project in southwest Greenland, following approval from the Government of Greenland on September 1. An independent S-K 1300 Initial Assessment for the ST1 deposit at Sarfartoq has estimated a high-case pre-tax net present value of approximately $2.05 billion and a pre-tax internal rate of return of 118.6%. This underscores the project's significant economic potential.

Planned annual neodymium-praseodymium (NdPr) oxide production from ST1 would equal approximately 34% of current NdPr oxide refining outside China, based on 2025 consumption levels, during each of the project's nine scheduled operating years. This positions Greenland Mines as a potentially major supplier in the non-Chinese rare earth market, which is strategically important given global supply chain diversification efforts.

In a reshaping of its board, Riad El-Dada and Dr. Shalom Hirschman have stepped down, with capital markets veteran Jason Hawkins joining as the company advances the Sarfartoq project and its Skaergaard palladium-gold-platinum project in southeast Greenland.

The company's strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals, and selected midstream processing opportunities. It is also advancing its broader North Atlantic Critical Metals Corridor vision, which aims to link Greenland resources with allied downstream jurisdictions and industrial infrastructure.

These developments highlight the growing importance of rare earth elements, particularly NdPr, which are essential for permanent magnets used in electric vehicles, wind turbines, and other clean energy technologies. With China dominating global refining capacity, Greenland Mines' progress on the Sarfartoq project could contribute to reducing this dependency.

Investors and industry observers will be watching closely as Greenland Mines executes its strategic plan, with the biotech spin-off expected to unlock value and allow the market to separately value its mining and biotech operations. The company's ability to deliver on its project milestones will be crucial in determining its role in the critical minerals supply chain.